Pellinen et al., 2009 - Google Patents
β1 integrin regulationPellinen et al., 2009
View PDF- Document ID
- 8137059741696076004
- Author
- Pellinen T
- et al.
- Publication year
External Links
Snippet
β1 Integrin Regulation Page 1 TURUN YLIOPISTON JULKAISUJA ANNALES
UNIVERSITATIS TURKUENSIS SARJA - SER. D OSA - TOM. 846 MEDICA -
ODONTOLOGICA TURUN YLIOPISTO Turku 2009 β1 Integrin Regulation by Teijo Pellinen …
- 108010022222 Integrin beta1 0 title description 146
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Giampazolias et al. | Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity | |
| Hermiston et al. | CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells | |
| Yagi et al. | A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells | |
| Kabashima et al. | Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism | |
| Imhof et al. | Adhesion mechanisms regulating the migration of monocytes | |
| Brdičková et al. | LIME: a new membrane Raft-associated adaptor protein involved in CD4 and CD8 coreceptor signaling | |
| Abram et al. | Convergence of immunoreceptor and integrin signaling | |
| Vestweber et al. | Similarities and differences in the regulation of leukocyte extravasation and vascular permeability | |
| Rubtsov et al. | Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response | |
| Coquery et al. | Regulatory roles of the tumor necrosis factor receptor BCMA | |
| JP5305553B2 (en) | Composition for inhibiting the growth of cancer cells | |
| Kumanogoh et al. | Biological functions and signaling of a transmembrane semaphorin, CD100/Sema4D | |
| de Gorter et al. | The small GTPase Ral mediates SDF-1–induced migration of B cells and multiple myeloma cells | |
| Hong et al. | LPA1-mediated inhibition of CXCR4 attenuates CXCL12-induced signaling and cell migration | |
| Montuori et al. | The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor | |
| Day et al. | Syntaxins 3 and 4 mediate vesicular trafficking of α5β1 and α3β1 integrins and cancer cell migration | |
| Pellinen | β1 integrin regulation | |
| Wang et al. | RhoH plays distinct roles in T-cell migrations induced by different doses of SDF1α | |
| Sanchez | Regulation of CCR7 Signaling Events by G-Protein-Coupled Receptor Kinases 2 and 3 | |
| 홍종민 | The role of CXCR4-LPA1 heteromer in CXCL12-mediated cell signaling and migration | |
| Hajaj et al. | Alternative splicing of SLAMF6 in human T cells creates a co-stimulatory isoform that counteracts the inhibitory effect of the full-length receptor | |
| Holen et al. | Ephrin‐B3 Binds Specifically to B Lymphocytes in Blood and Induces Migration | |
| Moro et al. | Regulation of MCP-3 and BRCA2 mRNA expression levels by β1 integrins | |
| Mele | Role of CD38 in chronic lymphocytic leukaemia cell motility | |
| Orsetti | Sufficiency of Intercellular Adhesion Molecule-1 in a Novel Secretory Process in Macrophages |